Analyst Ratings for Talis Biomedical Corp. (TLIS)
TLIS Rating Summary
TLIS Price Target Summary
- Highest: $9.00 (Piper Sandler)
- Lowest: $1.00 (BTIG)
- Average: $5.00
* Over Last 12-Mos
Overall Rating:
SELL
Rating Trend:
Avg. $ Target:
$5.00 (+488.2%)
* Over Last 12-Mos
Rating Score: 0 / 10
Percentile Rank: 0%
Avg. $ Target:
$5.00 (+488.2%)
* Over Last 12-Mos
Rating Score: 0 / 10
Percentile Rank: 0%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/18/2022 | BTIG | Mark A. Massaro | Downgrade | Sell (Neutral) |
1.00 (N/A) |
1.42 (0.85) |
-40.14% | Details |
| 1/7/2022 | BofA Securities | Derik de Bruin | Downgrade | Underperform (Neutral) |
3.00 (N/A) |
3.53 (0.85) |
-75.92% | Details |
 |
||||||||
|
||||||||
